Safety Alert for CIRCUMCISION CLAMPS: (1) GOMCO, (2) GOMCO-TYPE, (3) MOGEN, (4) MOGEN-TYPE

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by ALLIED HEALTHCARE PRODUCTS INC; FABRICANTE NÃO IDENTIFICADO NA PUBLICAÇÃO; MOGEN CIRCUMCISION INSTRUMENTS LTD.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    162
  • Date
    2000-10-27
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    UNTIL THIS DATE DOES NOT CONSERT PRODUCT REGISTRATION IN BRAZIL
  • Reason
    The united states central for devices and radiological health (cdrh) / food and drug administration published a security notification informing hospitals that had received 105 injury reports involving the circumvention reports mentioned between july 1996 and january 2000. the use of gomco and gomco-type graphics which have been returned by users, with parts of other manufacturers, or which have curved parts or malfuncted components, caused the breaking of the clamps, slipping, falling during use, penis tissue ruptures or failure in the lacre. the use of the mogen and mogen-type clamps which have opening dimensions of the arms greater than those specified by the manufacturer and the use of inappropriate sizes may cause patients injury. in these cases, the clip may allow the passage of an excessive quantity of fabric for the opening of the equipment, facilitating therefore the removal of an excessive quantity of preparation and, in some cases, of a piece of the glen of the penis.
  • Action
    CDRH RECOMMENDS HOSPITALS TO EXAMINE YOUR CLIPS TO DETERMINE WHETHER ALL PARTS ARE AVAILABLE, NOT DAMAGED, AND WITHIN THE MANUFACTURER'S SPECIFICATIONS. CDRH / FDA MAKES THE FOLLOWING RECOMMENDATIONS FOR GOMCO AND GOMCO-TYPE CLAMPS: (1) IF YOU CAN NOT CERTIFY THAT THE CLIP IS PART OF AN ORIGINAL CLIP, OR IF THE CLIP HAS LOST TO THE THREAD, BE WITH THE BASE OR THE HARMED ARM, TOOTHED TEETH OR THE DAMAGED RINGER, PLEASE CONTACT YOUR LOCAL REPRESENTATIVE OR DIRECTLY WITH THE MANUFACTURER TO OBTAIN REPLACEMENT PARTS OR DISPOSE THE CLAMP. (2) WHEN REQUESTING REPLACEMENT PARTS, CHECK WITH THE MANUFACTURER OR SUPPLIER, IF THE PARTS REQUESTED ARE COMPATIBLE WITH THE OTHER COMPONENTS OF YOUR EQUIPMENT. DO NOT REPLACE PARTS OF DIFFERENT STAPLER MANUFACTURER. (3) MAKE SURE TO REMOVE THE CLIP ONLY WITH THE OWN PARTS OF THE CLIP. DO NOT MIX DIFFERENT CLAMP PARTS, EVEN IF THEY ARE THE SAME MANUFACTURER UNLESS THE MANUFACTURER HAS ENSURED THAT THE PARTS ARE COMPATIBLE. (4) IF YOU DECIDE TO MARK THE CLAMP PARTS TO ENSURE THE CORRECT REMOVAL OF THESE INSTRUCTIONS, ASK THE FIRST MANUFACTURER BECAUSE SOME METHODS OF BRANDING MAY FACE THE CLAMP OR COMPROMISE YOUR STERILIZATION CAPACITY. CDRH MAKES THE FOLLOWING RECOMMENDATIONS FOR MOGEN AND MOGEN-TYPE CLAMS: (1) MAKE SURE THE USED CLIPS ARE OF SIZE APPROPRIATE TO THE PATIENT. SOME MANUFACTURERS PRODUCE TWO TYPES OF CLIPS, ONE FOR ADULTS AND ONE FOR CHILDREN. (2) PERIODICALLY, MEASURE THE INTERVAL BETWEEN THE CLAMP CLAMP TO ENSURE THAT THIS IS WITHIN THE MANUFACTURER SPECIFICATIONS. THE USE OF EQUIPMENT WITH INAPPROPRIATE CLOSURE OPENING CAN ALLOW THE PENIS PONY TO BE PULLED UNDERVERTED BY THE CLAMP WITH THE PREPARATION CAUSING INJURY. FOR FURTHER INFORMATION, PLEASE CONTACT SHERRY PURVIS-WYNN, CDRH, BY EMAIL AT PHANN@CDRH.FDA.GOV OR MAIL AT OFFICE OF SURVEILLANCE AND BIOMETRICS (HFZ-510), 1350 PICCARD DRIVE, ROCKVILLE MD 20850 ; BY PHONE 1 (301) 594-0650; OR FAX (301) 594-2968.